43 results on '"Lee, Cerina"'
Search Results
2. Risk of depressive disorders associated with medical cannabis authorization: A propensity score matched cohort study
3. Appropriateness of COVID-19 public health guidelines for an Alberta First Nations community
4. Mental health experiences with COVID-19 public health measures in an Alberta First Nations Community
5. Cohort study of medical cannabis authorisation and healthcare utilisation in 2014—2017 in Ontario, Canada
6. Feasibility, acceptability, and efficacy of a positive emotion regulation intervention to promote resilience for healthcare workers during the COVID-19 pandemic: A randomized controlled trial.
7. The association of burnout with work absenteeism and the frequency of thoughts in leaving their job in a cohort of healthcare workers during the COVID-19 pandemic
8. Effectiveness of RADAR on diabetes processes of care for First Nations communities in Alberta, Canada
9. Opioid use in medical cannabis authorization adult patients from 2013 to 2018: Alberta, Canada
10. Cohort study of medical cannabis authorization and motor vehicle crash-related healthcare visits in 2014–2017 in Ontario, Canada
11. Gaps in evidence for the use of medically authorized cannabis: Ontario and Alberta, Canada
12. Medical cannabis authorization and the risk of cardiovascular events: a longitudinal cohort study
13. Effectiveness of RADAR on diabetes processes of care for First Nations communities in Alberta, Canada.
14. Benzodiazepine Use in Medical Cannabis Authorization Adult Patients from 2013-2021: Alberta, Canada
15. Defining opioid naïve and implications for monitoring opioid use: A population‐based study in Alberta, Canada
16. Defining opioid naïve and implications for monitoring opioid use: A population‐based study in Alberta, Canada.
17. Intentions for uptake of the coronavirus disease 2019 (COVID-19) vaccine booster in healthcare workers
18. Defining opioid naïve and implications for monitoring opioid use: A population-based study in Alberta, Canada
19. Psychological wellbeing and the association with burnout in a cohort of healthcare workers during the COVID-19 pandemic
20. Chapter 6 - The use of medical cannabis: A focus on Canada—Cannabis, Cannabinoids, and Endocannabinoids
21. Incidence and Predictors of Cannabis-Related Poisoning and Mental and Behavioral Disorders among Patients with Medical Cannabis Authorization: A Cohort Study
22. Additional file 1 of Mental health experiences with COVID-19 public health measures in an Alberta First Nations Community
23. Additional file 2 of Mental health experiences with COVID-19 public health measures in an Alberta First Nations Community
24. Substance Use Disorders and Psychoactive Drug Poisoning in Medically Authorized Cannabis Patients: Longitudinal Cohort Study
25. Mental Health Experiences With COVID-19 Public Health Measures in an Alberta First Nations Community
26. Generalized Anxiety Disorder 7-Item (GAD-7) Scores in Medically Authorized Cannabis Patients—Ontario and Alberta, Canada
27. Incidence and Predictors of Cannabis-Related Poisoning and Mental and Behavioral Disorders Among Patients with Medical Cannabis Authorization: A Cohort Study
28. Is there a need for pneumococcal vaccination programs for the homeless to prevent invasive pneumococcal disease?
29. Medical Cannabis Authorization and the Risk of Cardiovascular Events: A Longitudinal Cohort Study
30. Additional file 1 of Medical cannabis authorization and the risk of cardiovascular events: a longitudinal cohort study
31. Additional file 2 of Opioid use in medical cannabis authorization adult patients from 2013 to 2018: Alberta, Canada
32. Substance Use Disorders and Psychoactive Drug Poisoning in Medically Authorized Cannabis Patients: Longitudinal Cohort Study.
33. Generalized Anxiety Disorder 7-Item (GAD-7) Scores in Medically Authorized Cannabis Patients—Ontario and Alberta, Canada.
34. Gaps in Evidence for the Use of Medically Authorized Cannabis: Ontario and Alberta, Canada
35. Opioid Use in Medical Cannabis Authorization Adult Patients from 2013-2018: Alberta, Canada
36. Cohort Study of Medical Cannabis Authorization and Motor Vehicle Crash-Related Healthcare Visits in 2014-2017 in Ontario, Canada
37. Contributors
38. Changes in patient health questionnaire (PHQ-9) scores in adults with medical authorization for cannabis
39. Cohort study of medical cannabis authorisation and healthcare utilisation in 2014–2017 in Ontario, Canada
40. sj-docx-1-cpa-10.1177_07067437211043393 - Supplemental material for Generalized Anxiety Disorder 7-Item (GAD-7) Scores in Medically Authorized Cannabis Patients—Ontario and Alberta, Canada
41. sj-docx-1-cpa-10.1177_07067437211060597 - Supplemental material for Substance Use Disorders and Psychoactive Drug Poisoning in Medically Authorized Cannabis Patients: Longitudinal Cohort Study
42. sj-docx-1-cpa-10.1177_07067437211060597 - Supplemental material for Substance Use Disorders and Psychoactive Drug Poisoning in Medically Authorized Cannabis Patients: Longitudinal Cohort Study
43. sj-docx-1-cpa-10.1177_07067437211043393 - Supplemental material for Generalized Anxiety Disorder 7-Item (GAD-7) Scores in Medically Authorized Cannabis Patients—Ontario and Alberta, Canada
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.